December 25, 2014 5:59 AM ET

Pharmaceuticals

Company Overview of Pericor Science Incorporated

Company Overview

Pericor Science Incorporated, a development stage biopharmaceutical company, develops therapeutics by using the TransLink System to enhance existing drugs or therapeutic molecules. Its lead compound, PTI 101, is a TransLink direct thrombin inhibitor for thrombosis and stenosis. The company was founded in 1999 and is based in Boston, Massachusetts.

50 Rowes Wharf

Boston, MA 02110

United States

Founded in 1999

Phone:

781-419-4015

Fax:

781-419-4068

Key Executives for Pericor Science Incorporated

Chief Executive Officer
Co-Founder
Co-Founder
Vice President of Research and Member of Management Board
Member of Management Board and Director
Age: 59
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Contract Pharmaceuticals Limited Niagara United States
DesigneRx Pharmaceuticals, Inc. United States
VasculoMedics Inc. United States
Genesis Today, Inc. United States
Sopherion Therapeutics, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pericor Science Incorporated, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.